York University scientists have found that beta blockers could potentially reverse heart failure.

QuintilesIMS’ Orchestrated Customer Engagement software aims to build synergies among commercial teams.

OmniComm Systems, which owns early-phase clinical trial electronic data capture software TrialOne, has nailed a major CRO deal worth $11.7 million.

Outcome Health, a healthcare intelligence tech firm, has raised an outsize $500 million first round of funding, valuing it at $5.5 billion.

A collaborative effort has developed a synthetic viral genome for bone cancer research and may prove revolutionary in the battle against cancer overall.

Just about a year after filing its IPO application BGI hits a big wall with a regulatory review.

Microbiome data is now part of Repositive’s Specialised Data Collections and offers researchers 21,000 data sets from human metagenomic studies.

Berg is applying its technology to breast cancer samples gathered by a Department of Defense program.